First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro
- Debora Wernitznig (Corresponding author)
- , Konstantinos Kiakos
- , Giorgia Del Favero
- , Nathalie Harrer
- , Herwig Machat
- , Annika Osswald
- , Michael A. Jakupec
- , Andreas Wernitznig
- , Wolfgang Sommergruber
- , Bernhard K. Keppler
Publications: Contribution to journal › Article › Peer Reviewed